ArticleHeliyon2024
Laryngeal disease classification using voice data: Octave-band vs. mel-frequency filters.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Early Detection of Glottic Cancer Through Machine Learning and Acoustic Voice Analysis: A Systematic Review.Medical sciences (Basel, Switzerland) · 2026Pooled it
- From voice biomarkers to telemedicine screening: developing and evaluating a voice-based AI model for laryngeal lesion detection using the Bridge2AI-Voice dataset.Frontiers in digital health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Laryngeal cancer diagnosis relies on specialist examinations, but non-invasive methods using voice data are emerging with artificial intelligence (AI) advancements. Mel Frequency Cepstral Coefficients (MFCCs) are widely used for voice analysis, but Octave Frequency Spectrum Energy (OFSE) may offer better accuracy in detecting subtle voice changes. Problem statement: Accurate early diagnosis of laryngeal cancer through voice data is challenging with current methods like MFCC. Objectives: This study compares the effectiveness of MFCC and OFSE in classifying voice data into healthy, laryngeal cancer, benign mucosal disease, and vocal fold paralysis categories. Methods: Voice samples from 363 patients were analyzed using CNN models, employing MFCC and OFSE with 1/3 octave band filters. Grad-Class Activation Mapping (Grad-CAM) was used to visualize key voice features. Results: OFSE with 1/3 octave band filters outperformed MFCC in classification accuracy, especially in multi-class classification including laryngeal cancer, benign mucosal disease, and vocal fold paralysis groups (0.9398 ± 0.0232 vs. 0.7061 ± 0.0561). Grad-CAM analysis revealed that OFSE with 1/3 octave band filters effectively distinguished laryngeal cancer from healthy voices by focusing on increased noise in the over-formant area and changes in the fundamental frequency. The analysis also highlighted that specific narrow frequency areas, particularly in vocal fold paralysis, were critical for classification, and benign mucosal diseases occasionally resembled healthy voices, making AI differentiation between benign conditions and laryngeal cancer a significant challenge. Conclusion: OFSE with 1/3 octave band filters provides superior accuracy in diagnosing laryngeal diseases including laryngeal cancer, showing potential for non-invasive, AI-driven early detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.